(Q42452538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

7

Keiji Wakabayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

Naoko Niho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

3

Yutaka Shoji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

4

Yoshito Takeuchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

5

Satoshi Matsubara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

6

Takashi Sugimura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

960-964

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14611672%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

PPARdelta is a very low-density lipoprotein sensor in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X

Inhibition of adipogenesis by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01385.X